In this follow-up to our original GLP-1 episode, we revisit the conversation around Ozempic, Wegovy, and Mounjaro with fresh updates as of September 29. We cover where things stand now, what the latest research and headlines are saying, how these medications are shaping the future of weight loss, and most importantly, how coaching still plays a critical role. If you're using GLP-1s, considering them, or coaching clients who are, this episode breaks down how to integrate them into real life with intention, strategy, and long-term success in mind.

Ver todos los episodios